Pettee Investors, Inc. Merck & Co., Inc. Transaction History

Pettee Investors, Inc.

$200 Million
Q3 2024

A detailed history of Pettee Investors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pettee Investors, Inc. holds 16,514 shares of MRK stock, worth $1.59 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

16,514

Previous 16,514 -0.0%

Holding current value

$1.59 Million

Previous $2.04 Million 8.27%

% of portfolio

0.94%

Previous 1.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$123.8 - $132.96 $1.73 Million - $1.86 Million	-14,000 Reduced 45.88%	16,514 $2.04 Million
Q1 2024 May 09, 2024	SELL	$113.24 - $131.95 $276,758 - $322,485	-2,444 Reduced 7.42%	30,514 $4.03 Million
Q3 2023 Oct 20, 2023	SELL	$102.95 - $114.33 $226,490 - $251,526	-2,200 Reduced 6.26%	32,958 $3.39 Million
Q3 2022 Nov 09, 2022	SELL	$84.53 - $94.96 $65,426 - $73,499	-774 Reduced 2.15%	35,158 $3.03 Million
Q2 2022 Jul 25, 2022	SELL	$83.49 - $94.64 $18,284 - $20,726	-219 Reduced 0.61%	35,932 $3.28 Million
Q2 2021 Aug 02, 2021	SELL	$70.31 - $77.77 $34,592 - $38,262	-492 Reduced 1.34%	36,151 $2.81 Million
Q4 2020 Feb 08, 2021	SELL	$71.77 - $79.65 $3,588 - $3,982	-50 Reduced 0.14%	36,643 $3 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $11,637 - $13,131	-150 Reduced 0.41%	36,693 $3.34 Million
Q3 2019 Oct 30, 2019	SELL	$76.08 - $82.93 $6,390 - $6,966	-84 Reduced 0.23%	36,843 $3.1 Million
Q2 2019 Aug 07, 2019	SELL	$69.84 - $81.59 $41,065 - $47,974	-588 Reduced 1.57%	36,927 $3.1 Million
Q4 2018 Feb 06, 2019	SELL	$65.24 - $75.71 $35,490 - $41,186	-544 Reduced 1.43%	37,515 $2.87 Million
Q3 2017 Nov 02, 2017	BUY	$58.67 - $63.13 $2.23 Million - $2.4 Million	38,059	38,059 $2.44 Million

Others Institutions Holding MRK

# of Institutions

3,821

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pettee Investors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pettee Investors, Inc. with notifications on news.

Account

Pettee Investors, Inc. Merck & Co., Inc. Transaction History